Europe Colorectal Cancer Market 2027 By Modality, End User, and Country | The Insight Partners

Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country

Publication Month: Feb 2020 | Report Code: TIPRE00009258 | No. of Pages: 229 | Category: Medical Device | Status: Published
Covid

Europe, the colorectal cancer market, is anticipated to reach US$ 5,573.2 Mn in 2027 from US$ 4,241.2 Mn in 2019. The market is projected to grow with a CAGR of 3.5% from 2020-2027.


The rise of the colorectal cancer market is driven by factors such as the increasing prevalence of colorectal cancer, and benefits offered by generic drugs that are boosting the market over the years. But, pricing pressure on drug manufacturers is likely to hinder the growth of the market in the future years.

 

Generic drugs are alternatives of branded drugs. The pharmacological effects of generic drugs are similar to their branded counterparts. Generic drugs are cost-effective as the manufacturers does not invest in the development and marketing a new drug. After the expiry of a drug patent, other manufacturers apply for FDA approval of a generic intended for its manufacturing and selling. Thus, the generic drugs are cheaper than their branded counterparts. The generic drug have exactly the same dosage, effects, side effects, route of administration, risks, safety, and strength as that of the original branded drugs. Generic drugs are important in oncology due to the fact that some of the anticancer drugs are only offered as generics. Patients are likely seen to abandon branded prescriptions which are majorly associated with their higher co-pays. Among developing countries such as India, where the paying capacity is relatively low, generic drugs for cancer treatment acts as a boon for both the manufacturers as well as patients due to its affordability and efficacy. For instance, in June 2016, Hetero launched a Biosimilar 'Bevacizumab' for the treatment of metastatic colorectal cancer under the brand name “Cizumab”. One of the most striking benefit of using generic drugs is the cost that is up to 85% less than that of the branded drugs.

 

In 2019, the Germany accounted for the largest market share in Europe colorectal cancer market, and it is also expected to grow at a faster pace over the forecast period. The market for colorectal cancer in the country is expected to grow due to the rising development in the field of cancer. Across the country, there are various biopharmaceutical and pharmaceutical companies. Various multinational companies are conducting market consolidation strategies to expand the oncology segment. Hence, considering the mentioned factors, the colorectal cancer market is expected to grow at a significant pace in the US during the forecast period.

 

Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Germany Colorectal Cancer Market

Get more information on this report :


 

EUROPE COLORECTAL CANCER – MARKET SEGMENTATION

By Modality

  • Diagnosis Type
    • Immunohistochemistry
    • Stool Test
    • Flexible Sigmoidoscopy
    • Colonoscopy
    • CEA Test
    • Others
  • Therapy Type
    • Chemotherapy
    • Alkylating Agent
    • Antimetabolites
    • Others
    • Immunotherapy
    • Panitumumab
    • Cetuximab
    • Bevacizumab
    • Others
    • Chemoprotectant
    • Others
  • Imaging Type
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Others


By End User

  • Hospitals
  • Diagnostic and Research Laboratories

 

By Geography

  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe

 

Company Profiles

  • Epigenomics AG
  • Novigenix SA
  • Clinical Genomics Technologies Pty Ltd.
  • EDP Biotech Corporation
  • Volitionrx Limited
  • Abbott Laboratories
  • Amgen Inc.
  • F. Hoffmann-La Roche AG
  • Bruker Corporation
  • Quest Diagnostics Incorporated
  • Natera, Inc.
  • Guardant Health, Inc.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Colorectal Cancer Market – By Modality

1.3.2        Europe Colorectal Cancer Market – By End User

1.3.3        Europe Colorectal Cancer Market – By Country

2.           Europe Colorectal Cancer Market –  Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Colorectal Cancer Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Colorectal Cancer Market - Europe PEST Analysis

5.           Europe Colorectal Cancer Market -  Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Prevalence Of Colorectal Cancer

5.1.2        Benefits Offered By Generic Drugs

5.2         Key Restraints

5.2.1        Pricing Pressure On Drug Manufacturers

5.3         Key Market Opportunities

5.3.1        Rising Healthcare Expenditure in Europe

5.4         Future Trend

5.4.1        Inclination Towards Personalized Medicine

5.5         Impact Analysis

6.           Colorectal Cancer Market – Europe Analysis

6.1         Europe Colorectal Cancer Market Revenue Forecasts and Analysis

6.2         Positioning Of Key Players

7.           Europe Colorectal Cancer Market Analysis And Forecasts To 2027 – Modality

7.1         Overview

7.2         Europe Colorectal Cancer Market, By Modality 2019 & 2027 (%)

7.2.1        Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

7.2.1.1          Europe Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

7.2.1.2          Europe Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

7.2.1.2.1          Europe Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

7.2.1.2.2          Europe Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

7.2.1.3          Europe Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

7.3         Diagnosis Type Market

7.3.1        Overview

7.3.2        Diagnosis Type Market Revenue and Forecast to 2027 (US$ Mn)

7.3.3        Immunohistochemistry Market

7.3.3.1          Overview

7.3.3.2          Immunohistochemistry Market Revenue and Forecast to 2027 (US$ Mn)

7.3.4        Stool Test Market

7.3.4.1          Overview

7.3.4.2          Stool Test Market Revenue and Forecast to 2027 (US$ Mn)

7.3.5        Flexible Sigmoidoscopy Market

7.3.5.1          Overview

7.3.5.2          Flexible Sigmoidoscopy Market Revenue and Forecast to 2027 (US$ Mn)

7.3.6        Colonoscopy Market

7.3.6.1          Overview

7.3.6.2          Colonoscopy Market Revenue and Forecast to 2027 (US$ Mn)

7.3.7        CEA Test Market

7.3.7.1          Overview

7.3.7.2          CEA Test Market Revenue and Forecast to 2027 (US$ Mn)

7.3.8        Other Test Market

7.3.8.1          Overview

7.3.8.2          Other Test Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Therapy Type Market

7.4.1        Overview

7.4.2        Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.3        Chemotherapy Market

7.4.3.1          Overview

7.4.3.2          Chemotherapy Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3.3          Alkylating Agent Market

7.4.3.3.1          Overview

7.4.3.3.2          Alkylating Agent Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3.4          Antimetabolites Market

7.4.3.4.1          Antimetabolites Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3.5          Others Market

7.4.3.5.1          Others Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4        Immunotherapy Market

7.4.4.1          Overview

7.4.4.2          Immunotherapy Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4.3          Panitumumab Market

7.4.4.3.1          Overview

7.4.4.3.2          Panitumumab Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4.4          Cetuximab Market

7.4.4.4.1          Overview

7.4.4.4.2          Cetuximab Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4.5          Bevacizumab Market

7.4.4.5.1          Overview

7.4.4.5.2          Bevacizumab Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4.6          Others Market

7.4.4.6.1          Overview

7.4.4.6.2          Others Market Revenue and Forecast to 2027 (US$ Mn)

7.4.5        Chemoprotectant Market

7.4.5.1          Overview

7.4.5.2          Chemoprotectant Market Revenue and Forecast to 2027 (US$ Mn)

7.4.6        Others Market

7.4.6.1          Overview

7.4.6.2          Others Market Revenue and Forecast to 2027 (US$ Mn)

7.5         Imaging Type Market

7.5.1        Overview

7.5.2        Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)

7.5.3        Computed Tomography (CT) Market

7.5.3.1          Overview

7.5.3.2          Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)

7.5.4        Magnetic Resonance Imaging (MRI) Market

7.5.4.1          Overview

7.5.4.2          Magnetic Resonance Imaging (MRI) Market Revenue and Forecast to 2027 (US$ Mn)

7.5.5        Others Market

7.5.5.1          Overview

7.5.5.2          Others Market Revenue and Forecast to 2027 (US$ Mn)

8.           Europe Colorectal Cancer Market Analysis– By End User

8.1         Overview

8.2         Europe Colorectal Cancer Market, By End User 2019 & 2027 (%)

8.2.1        Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

8.3         Hospitals Market

8.3.1        Overview

8.3.2        Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

8.4         Diagnostic and Research Laboratories Market

8.4.1        Overview

8.4.2        Europe Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Colorectal Cancer Market Revenue And Forecasts To 2027 – Geographical Analysis

9.1         Europe Colorectal Cancer Market Revenue and Forecasts To 2027

9.1.1        Overview

9.1.2        Europe Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.3        Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

9.1.3.1          Europe Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.3.2          Europe Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.3.2.1          Europe Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.3.2.2          Europe Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.3.3          Europe Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.4        Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.1.5        Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)

9.1.6        Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1          Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2          Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

9.1.6.2.1          Germany Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.2.2          Germany Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.2.2.1       Germany Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.2.2.2       Germany Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.2.3          Germany Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.3          Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.1.7        UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1          UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2          UK Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

9.1.7.2.1          UK Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.2.2          UK Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.2.2.1       UK Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.2.2.2       UK Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.2.3          UK Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.3          UK Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.1.8        France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1          France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.2          France Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

9.1.8.2.1          France Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.2.2          France Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.2.2.1       France Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.2.2.2       France Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.2.3          France Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.3          France Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.1.9        Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9.1          Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9.2          Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

9.1.9.2.1          Spain Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.9.2.2          Spain Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.9.2.2.1       Spain Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.9.2.2.2       Spain Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.9.2.3          Spain Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.9.3          Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.1.10     Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.10.1       Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.10.2       Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)

9.1.10.2.1       Italy Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.10.2.2       Italy Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.10.2.2.1    Italy Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.10.2.2.2    Italy Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.10.2.3       Italy Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.10.3       Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.        Europe Colorectal Cancer Market- Industry Landscape

10.1      Overview

10.2      Growth Strategies In The Colorectal Cancer Market, 2016-2019

10.3      Organic Developments

10.3.1     Overview

10.3.2     Organic Growth Strategies In The Colorectal Cancer Market, 2016-2019

10.4      Inorganic Developments

10.4.1     Overview

10.4.2     Inorganic Growth Strategies In The Colorectal Cancer Market, 2016-2019

11.        Colorectal Cancer Market–Key Company Profiles

11.1      Epigenomics AG

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Financial Overview

11.1.4     Product Portfolio

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Novigenix SA

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Financial Overview

11.2.4     Product Portfolio

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Clinical Genomics Technologies Pty Ltd.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Financial Overview

11.3.4     Product Portfolio

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      EDP Biotech Corporation

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Financial Overview

11.4.4     Product Portfolio

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Volitionrx Limited

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Financial Overview

11.5.4     Product Portfolio

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Abbott Laboratories

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Financial Overview

11.6.4     Product Portfolio

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Amgen Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Financial Overview

11.7.4     Product Portfolio

11.7.5     Pipeline (Clinical Trials) Portfolio

11.7.6     SWOT Analysis

11.7.7     Key Developments

11.8      F. Hoffmann-La Roche AG

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Financial Overview

11.8.4     Product Portfolio

11.8.5     Pipeline (Clinical Trials) Portfolio

11.8.6     SWOT Analysis

11.8.7     Key Developments

11.9      Bruker Corporation

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Financial Overview

11.9.4     Product Portfolio

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10   Quest Diagnostics Incorporated

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Financial Overview

11.10.4  Product Portfolio

11.10.5  SWOT Analysis

11.10.6  Key Developments

11.11   Natera, Inc.

11.11.1  Key Facts

11.11.2  Business Description

11.11.3  Financial Overview

11.11.4  Product Portfolio

11.11.5  SWOT Analysis

11.11.6  Key Developments

11.12   Guardant Health, Inc.

11.12.1  Key Facts

11.12.2  Business Description

11.12.3  Financial Overview

11.12.4  Product Portfolio

11.12.5  SWOT Analysis

11.12.6  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)

Table 2.             Europe Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 3.             Europe Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 4.             Europe Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 5.             Europe Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 6.             Europe Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 7.             Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 8.             Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)

Table 9.             Europe Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 10.          Europe Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 11.          Europe Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 12.          Europe Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 13.          Europe Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 14.          Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 15.          Germany Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)

Table 16.          Germany Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 17.          Germany Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 18.          Germany Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 19.          Germany Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 20.          Germany Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 21.          Germany Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 22.          UK Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)

Table 23.          UK Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 24.          UK Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 25.          UK Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 26.          UK Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 27.          UK Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 28.          UK Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 29.          France Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)

Table 30.          France Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 31.          France Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 32.          France Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 33.          France Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 34.          France Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 35.          France Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 36.          Spain Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)

Table 37.          Spain Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 38.          Spain Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 39.          Spain Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 40.          Spain Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 41.          Spain Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 42.          Spain Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 43.          Italy Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)

Table 44.          Italy Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 45.          Italy Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 46.          Italy Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 47.          Italy Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 48.          Italy Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 49.          Italy Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 50.          Recent Organic Growth Strategies In The Colorectal Cancer Market

Table 51.          Recent Inorganic Growth Strategies In The Colorectal Cancer Market

Table 52.          Glossary of Terms, Colorectal Cancer Market
 

LIST OF FIGURES

Figure 1.           Colorectal Cancer Market Segmentation

Figure 2.           Europe Colorectal Cancer Market Overview

Figure 3.           Diagnosis Type Segment Held Largest Share Of Modality Segment In Colorectal Cancer Market

Figure 4.           Germany Is Expected To Show Remarkable Growth During The Forecast Period

Figure 5.           Europe Colorectal Cancer Market- Leading Country Markets (US$ Mn)

Figure 6.           Europe colorectal Cancer Market, Industry Landscape

Figure 7.           Colorectal Cancer Market - Europe PEST Analysis

Figure 8.           Comparison of Brand – Name Drugs and Generic Drugs

Figure 9.           Colorectal Cancer Market Impact Analysis of Drivers And Restraints

Figure 10.        Europe Colorectal Cancer Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 11.        Market Positioning Of Key Player In Europe Colorectal Cancer Market

Figure 12.        Europe Colorectal Cancer Market, by Modality 2019 & 2027 (%)

Figure 13.        Diagnosis Type Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Immunohistochemistry Market Revenue And Forecasts To 2027 (US$ MN)

Figure 15.        Stool Test Market Revenue And Forecasts To 2027 (US$ MN)

Figure 16.        Flexible Sigmoidoscopy Market Revenue And Forecasts To 2027 (US$ MN)

Figure 17.        Colonoscopy Market Revenue And Forecasts To 2027 (US$ MN)

Figure 18.        CEA Test Market Revenue And Forecasts To 2027 (US$ MN)

Figure 19.        Other Test Market Revenue And Forecasts To 2027 (US$ MN)

Figure 20.        Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Chemotherapy Market Revenue And Forecasts To 2027 (US$ MN)

Figure 22.        Alkylating Agent Market Revenue And Forecasts To 2027 (US$ MN)

Figure 23.        Antimetabolites Market Revenue And Forecasts To 2027 (US$ MN)

Figure 24.        Others Market Revenue And Forecasts To 2027 (US$ MN)

Figure 25.        Immunotherapy Market Revenue And Forecasts To 2027 (US$ MN)

Figure 26.        Panitumumab Market Revenue And Forecasts To 2027 (US$ MN)

Figure 27.        Cetuximab Market Revenue And Forecasts To 2027 (US$ MN)

Figure 28.        Bevacizumab Market Revenue And Forecasts To 2027 (US$ MN)

Figure 29.        Others Market Revenue And Forecasts To 2027 (US$ MN)

Figure 30.        Chemoprotectant Market Revenue And Forecasts To 2027 (US$ MN)

Figure 31.        Others Market Revenue And Forecasts To 2027 (US$ MN)

Figure 32.        Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33.        Computed Tomography (CT) Market Revenue And Forecasts To 2027 (US$ MN)

Figure 34.        Magnetic Resonance Imaging (MRI) Market Revenue And Forecasts To 2027 (US$ MN)

Figure 35.        Others Market Revenue And Forecasts To 2027 (US$ MN)

Figure 36.        Europe Colorectal Cancer Market, by End User 2019 & 2027 (%)

Figure 37.        Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38.        Europe Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 39.        Europe Colorectal Cancer Market Revenue Overview, By Country (2019) (US$ Mn)

Figure 40.        Europe Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41.        Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)

Figure 42.        Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43.        UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 44.        France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 45.        Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 46.        Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 47.        Growth Strategies In The Colorectal Cancer Market, 2016-2019

 

The List of Companies - Europe Colorectal Cancer Market

  1. Epigenomics AG
  2. Novigenix SA
  3. Clinical Genomics Technologies Pty Ltd.
  4. EDP Biotech Corporation
  5. Volitionrx Limited
  6. Abbott Laboratories
  7. Amgen Inc.
  8. F. Hoffmann-La Roche AG
  9. Bruker Corporation
  10. Quest Diagnostics Incorporated
  11. Natera, Inc.
  12. Guardant Health, Inc.

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe colorectal cancer market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the Europe colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00009258
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing